Asker publishes Annual and Sustainability Report 2024

During the year Asker completed 12 acquisitions, expanded into three new countries, and took several additional steps to advance progress in the healthcare sector.

In the Annual and Sustainability Report, CEO Johan Falk commented on Asker’s performance over the past year.

“2024 brought yet another year of global economic and geopolitical challenges, but the healthcare sector simply has to work to ensure that each patient receives the care and treatment they need. While the European MedTech market is stable, growing at 3-4% annually, the entrepreneurial drive of the companies in our Group, combined with Asker’s size, has allowed us to nearly double that growth. Our organic profit growth is growing even faster, as our companies gain market share and leverage economies of scale from being part of the expanding Asker family.”

This year, Asker’s sustainability report is following the EU Corporate Sustainability Reporting Directive (CSRD), enhancing transparency and comparability for our stakeholders.

Learn more about Asker’s growth journey and our commitment to supporting a more sustainable healthcare system in the Annual and Sustainability report 2024.

For further information, please contact:
Emma Rheborg, Head of Communication
Phone: +46 73 313 62 17
E-mail: [email protected]

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group – driving progress in the healthcare sector. The group has more than 4 000 employees in 17 countries and revenues amounting to SEK 16 billion.